While its precise role in the pathology remains unclear, the GDNF/RET pathway may contribute to neuroprotection, as indicated by studies on the ALS drug Edaravone, which appears to exert its neuroprotective effects through this signaling axis (Li et al., 2022). Here, GDNF is linked to amyotrophic lateral sclerosis.